Orthofix Medical (OFIX) Enterprise Value (2009 - 2026)

Orthofix Medical has disclosed Enterprise Value across 18 years of filings, most recently posting -$120.9 million for Q1 2026.

• Quarterly Enterprise Value fell 99.94% year-over-year to -$120.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$120.9 million (down 99.94% YoY) and the FY2025 annual result came in at -$85.1 million, up 0.73% from the prior year.
• Enterprise Value fell to -$120.9 million in Q1 2026, from -$85.1 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$28.9 million in Q2 2024 and troughed at -$120.9 million in Q1 2026.
• A 5-year average of -$57.1 million and a median of -$51.7 million in 2022 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2022 — Enterprise Value soared 42.29% — and 2025, when it tumbled 137.96%.
• Tracing OFIX's Enterprise Value over 5 years: stood at -$50.7 million in 2022, then climbed by 25.53% to -$37.8 million in 2023, then slumped by 127.08% to -$85.7 million in 2024, then climbed by 0.73% to -$85.1 million in 2025, then sank by 42.01% to -$120.9 million in 2026.
• Business Quant data shows OFIX's Enterprise Value at -$120.9 million in Q1 2026, -$85.1 million in Q4 2025, and -$65.9 million in Q3 2025.